Protein Science
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print March 1, 2005
Protein Science, DOI: 10.1110/ps.041219505
Copyright © 2005 The Protein Society
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ps.041219505v1
14/4/1071    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Veldkamp, C. T.
Right arrow Articles by Volkman, B. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Veldkamp, C. T.
Right arrow Articles by Volkman, B. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The monomer–dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin

Christopher T. Veldkamp, Francis C. Peterson, Adam J. Pelzek and Brian F. Volkman

Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA

(RECEIVED November 4, 2004; FINAL REVISION January 4, 2005; ACCEPTED January 4, 2005)

Chemokines, like stromal cell-derived factor-1 (SDF1/CXCL12), are small secreted proteins that signal cells to migrate. Because SDF1 and its receptor CXCR4 play important roles in embryonic development, cancer metastasis, and HIV/AIDS, this chemokine signaling system is the subject of intense study. However, it is not known whether the monomeric or dimeric structure of SDF1 is responsible for signaling in vivo. Previous structural studies portrayed the SDF1 structure as either strictly monomeric in solution or dimeric when crystallized. Here, we report two-dimensional NMR, pulsed-field gradient diffusion and fluorescence polarization measurements at various SDF1 concentrations, solution conditions, and pH. These results demonstrate that SDF1 can form a dimeric structure in solution, but only at nonacidic pH when stabilizing counterions are present. Thus, while the previous NMR structural studies were performed under acidic conditions that strongly promote the monomeric state, crystallographic studies used nonacidic buffer conditions that included divalent anions shown here to promote dimerization. This pH-sensitive aggregation behavior is explained by a dense cluster of positively charged residues at the SDF1 dimer interface that includes a histidine side chain at its center. A heparin disaccharide shifts the SDF1 monomer–dimer equilibrium in the same manner as other stabilizing anions, suggesting that glycosaminoglycan binding may be coupled to SDF1 dimerization in vivo.

Keywords: chemokines; heparin; NMR; fluorescence polarization; monomer–dimer equilibrium

Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.041219505.


Reprint requests to: Brian F. Volkman, Department of Biochemistry, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA; e-mail: bvolkman{at}mcw.edu; fax: (414) 456-6510.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Sci SignalHome page
C. T. Veldkamp, C. Seibert, F. C. Peterson, N. B. De la Cruz, J. C. Haugner III, H. Basnet, T. P. Sakmar, and B. F. Volkman
Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12
Sci. Signal., September 16, 2008; 1(37): ra4 - ra4.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Hachet-Haas, K. Balabanian, F. Rohmer, F. Pons, C. Franchet, S. Lecat, K. Y. C. Chow, R. Dagher, P. Gizzi, B. Didier, et al.
Small Neutralizing Molecules to Inhibit Actions of the Chemokine CXCL12
J. Biol. Chem., August 22, 2008; 283(34): 23189 - 23199.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. I. Chan, H. N. Hunter, B. F. Tack, and H. J. Vogel
Human Macrophage Inflammatory Protein 3{alpha}: Protein and Peptide Nuclear Magnetic Resonance Solution Structures, Dimerization, Dynamics, and Anti-Infective Properties
Antimicrob. Agents Chemother., March 1, 2008; 52(3): 883 - 894.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Jin, X. Shen, B. R. Baggett, X. Kong, and P. J. LiWang
The Human CC Chemokine MIP-1beta Dimer Is Not Competent to Bind to the CCR5 Receptor
J. Biol. Chem., September 21, 2007; 282(38): 27976 - 27983.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. W. Murphy, Y. Cho, A. Sachpatzidis, C. Fan, M. E. Hodsdon, and E. Lolis
Structural and Functional Basis of CXCL12 (Stromal Cell-derived Factor-1{alpha}) Binding to Heparin
J. Biol. Chem., March 30, 2007; 282(13): 10018 - 10027.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
A. Guyon and J.-L. Nahon
Multiple actions of the chemokine stromal cell-derived factor-1{alpha} on neuronal activity
J. Mol. Endocrinol., March 1, 2007; 38(3): 365 - 376.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
O. K. Baryshnikova and B. D. Sykes
Backbone dynamics of SDF-1{alpha} determined by NMR: Interpretation in the presence of monomer-dimer equilibrium.
Protein Sci., November 1, 2006; 15(11): 2568 - 2578.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. F. Paredes, G. Li, O. Berger, S. C. Baraban, and S. J. Pleasure
Stromal-Derived Factor-1 (CXCL12) Regulates Laminar Position of Cajal-Retzius Cells in Normal and Dysplastic Brains.
J. Neurosci., September 13, 2006; 26(37): 9404 - 9412.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
K. Altundag, O. Altundag, M. A. Atik, C. Boruban, M. B. Altundag, and S. Turen
Recent findings for anti-metastatic potential of heparin.
Clinical and Applied Thrombosis/Hemostasis, July 1, 2006; 12(3): 376 - 377.
[PDF]


Home page
JCOHome page
K. Altundag, O. Altundag, and M. A. Atik
Heparin and CXCL12 Dimerization
J. Clin. Oncol., October 1, 2005; 23(28): 7248 - 7248.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by The Protein Society.